88 related articles for article (PubMed ID: 9135066)
1. The 96 kDa protein kinase activated by oncogenic Ras in Xenopus egg extracts is also activated by constitutively active Mek: activation requires serine/threonine phosphorylation.
Pan BT; Zhang Y; Brott B; Chen DH
Oncogene; 1997 Apr; 14(14):1653-60. PubMed ID: 9135066
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase-dependent overexpression of the nuclear protein pirin in c-JUN and RAS transformed fibroblasts.
Bergman AC; Alaiya AA; Wendler W; Binetruy B; Shoshan M; Sakaguchi K; Bergman T; Kronenwett U; Auer G; Appella E; Jörnvall H; Linder S
Cell Mol Life Sci; 1999 Mar; 55(3):467-71. PubMed ID: 10228560
[TBL] [Abstract][Full Text] [Related]
3. MAP kinase is required for the spindle assembly checkpoint but is dispensable for the normal M phase entry and exit in Xenopus egg cell cycle extracts.
Takenaka K; Gotoh Y; Nishida E
J Cell Biol; 1997 Mar; 136(5):1091-7. PubMed ID: 9060473
[TBL] [Abstract][Full Text] [Related]
4. Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src-transformed cells.
Stofega MR; Yu CL; Wu J; Jove R
Cell Growth Differ; 1997 Jan; 8(1):113-9. PubMed ID: 8993840
[TBL] [Abstract][Full Text] [Related]
5. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.
Lin AW; Barradas M; Stone JC; van Aelst L; Serrano M; Lowe SW
Genes Dev; 1998 Oct; 12(19):3008-19. PubMed ID: 9765203
[TBL] [Abstract][Full Text] [Related]
6. Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A.
Littlepage LE; Wu H; Andresson T; Deanehan JK; Amundadottir LT; Ruderman JV
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15440-5. PubMed ID: 12422018
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy.
Huang Y; Zhen Y; Chen Y; Sui S; Zhang L
Biochem Pharmacol; 2023 Nov; 217():115842. PubMed ID: 37802240
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors.
Howe AK; Gaillard S; Bennett JS; Rundell K
J Virol; 1998 Dec; 72(12):9637-44. PubMed ID: 9811697
[TBL] [Abstract][Full Text] [Related]
9. Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
Pehkonen H; Filippou A; Väänänen J; Lindfors I; Vänttinen M; Ianevski P; Mäkelä A; Munne P; Klefström J; Toppila-Salmi S; Grénman R; Hagström J; Mäkitie AA; Karhemo PR; Monni O
Mol Oncol; 2024 Mar; 18(3):662-676. PubMed ID: 38264964
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
[TBL] [Abstract][Full Text] [Related]
11. Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression.
Cacace AM; Michaud NR; Therrien M; Mathes K; Copeland T; Rubin GM; Morrison DK
Mol Cell Biol; 1999 Jan; 19(1):229-40. PubMed ID: 9858547
[TBL] [Abstract][Full Text] [Related]
12. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D.
Sulzmaier FJ; Valmiki MK; Nelson DA; Caliva MJ; Geerts D; Matter ML; White EP; Ramos JW
Oncogene; 2012 Jul; 31(30):3547-60. PubMed ID: 22105357
[TBL] [Abstract][Full Text] [Related]
13. The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo.
Rackley B; Seong CS; Kiely E; Parker RE; Rupji M; Dwivedi B; Heddleston JM; Giang W; Anthony N; Chew TL; Gilbert-Ross M
Commun Biol; 2021 Jan; 4(1):142. PubMed ID: 33514834
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract][Full Text] [Related]
15. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
[TBL] [Abstract][Full Text] [Related]
16. TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis.
Shi H; Ju Q; Mao Y; Wang Y; Ding J; Liu X; Tang X; Sun C
Adv Sci (Weinh); 2021 Mar; 8(5):2001575. PubMed ID: 33717835
[TBL] [Abstract][Full Text] [Related]
17. How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study.
Liu Y; Zhu J; Guo X; Huang T; Han J; Gao J; Xu D; Han W
J Biomol Struct Dyn; 2020 Aug; 38(13):3942-3958. PubMed ID: 31658877
[TBL] [Abstract][Full Text] [Related]
18. A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2.
Iijima M; Kubota Y; Sawa R; Kubota Y; Hatano M; Igarashi M; Kawada M; Momose I; Takekawa M; Shibasaki M
J Antibiot (Tokyo); 2017 Sep; ():. PubMed ID: 28874847
[TBL] [Abstract][Full Text] [Related]
19. RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
Bonsor DA; Simanshu DK
Annu Rev Cancer Biol; 2024 Jun; 8():97-113. PubMed ID: 38882927
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapy for MAPK Alterations in Pediatric Gliomas.
Truong AY; Nicolaides TP
Brain Disord Ther; 2015 Aug; Suppl 2():. PubMed ID: 26525348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
